The total return over the past 12 months is +271.55% vs. +16.94% for the S&P 500. So far it's up +207.83% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +271.55% | (17.41%) | (35.80%) | N/A | N/A | N/A |
| Total Return CAGR | +271.55% | (17.41%) | (35.80%) | N/A | N/A | N/A |
| Revenue CAGR | (15.11%) | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Rallybio Corporation (RLYB)
| Year | Start price | End price | RLYB Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $5.49 | $16.90 | +207.83% | +14.51% | +193.32% |
| 2025 | $7.68 | $5.49 | (28.52%) | +17.72% | (46.24%) |
| 2024 | $19.12 | $7.68 | (59.83%) | +24.89% | (84.72%) |
| 2023 | $52.56 | $19.12 | (63.62%) | +26.19% | (89.81%) |
| 2022 | $76.32 | $52.56 | (31.13%) | (18.17%) | (12.96%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
